Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Kronos Advanced Technologies Set Payment Date of June 22 for 1 DogeSPAC LLC Unit to be Paid for Each 1 Share of KNOS Held On Record Date of June 15, 2021
Press Release | 06/14/2021
Los Angeles, CA, June 14, 2021 (GLOBE NEWSWIRE) -- KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) ("KNOS" or the "Company"), an innovation-driven product development and production company that has significantly changed the way air is moved, filtered, and sterilized announced today that the Company set a payment date of June 22 20021 for the distribution to all shareholders, pro rata of 1 unit of DogeSPAC LLC for each share of KNOS held on June 15, 2021.
We understand that those who hold their shares through brokerage firms will be entitled to the dividend if they hold until an EX Dividend Date is set by FINRA based on KNOS' timely ten days prior notification, which may fall on a date after the payment date. If FINRA does not set an ex-dividend, it is our understanding that whoever held the shares through their brokerage firm on the close of business on the record date would be entitled to the distribution.
According to Investor.gov, if you purchase a stock on its ex-dividend date or after, you will not receive the dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date and hold up to the ex-dividend date, you get the dividend.
Kronos Advanced Technologies is history's first publicly-traded Company in the stock market to accept Dogecoin for its products and continues to encourage Dogecoin owners to purchase our revolutionary clean air products as the Company continues to foresee upside potential holding the popular meme coin and has profited substantially from making this calculated bet, although Doge, along with other major cryptocurrencies, has suffered severe volatility, recently.
With the Texas Department of Banking announcing that state-chartered banks have the authority to provide custody or safekeeping services for virtual currencies, we believe that Dogecoin becomes a more valuable asset to hold.
While the dividend will not be registered with the SEC, and therefore restricted until either the units are registered with the SEC, or an exemption from registration becomes available, at a yet to be determined date in the future, unitholders will then have the option to convert their LLC interests into Crypto units that will be tradeable on various Decentralized Cryptocurrencies Exchanges such as Uniswap and Pancakeswap. DogeSPAC LLC may also determine to register the units with the Securities and Exchange Commission, which would allow the LLC interests to be listed on an exchange if other certain conditions were to be met.
Updates on DogeSpac will be available at: www.dogespac.com
Purchases of our revolutionary clean air products can be purchased utilizing U.S. Dollars, Dogecoin as well as other cryptocurrencies by visiting our shopping portal: https://www.1800safeair.com
What Is Dogecoin? (CoinMarketCap.com)
"Dogecoin (DOGE) is based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. The open-source digital currency was created by Billy Markus from Portland, Oregon, and Jackson Palmer from Sydney, Australia, and was forked from Litecoin in December 2013. Dogecoin's creators envisaged it as a fun, light-hearted cryptocurrency that would have greater appeal beyond the core Bitcoin audience since it was based on a dog meme. Tesla CEO Elon Musk posted several tweets on social media that Dogecoin is his favorite coin."
About Kronos Advanced Technologies, Inc.
The Company was initially founded in 2002 and funded by the U.S. military to develop electrostatic air movers. Eventually, the Company moved into the consumer air purification business. It began operations as a product development company that invented and significantly changed the way air is moved, filtered, and sterilized. Historically, Kronos has focused on developing, marketing, and selling the Company's proprietary air movement and purification technology. Serving the Indoor Air Quality (IAQ) market, Kronos technology uses state-of-the-art high voltage patented processes without the use of traditional porous HEPA filters. Kronos-based products move air silently, filter, sterilize, and purify the air while dramatically reducing energy consumption to half of a 60-watt light bulb. Kronos devices can be variable in shape or size and, therefore, have the potential to be scaled-down for air purification in cars or scaled-up in size for industrial and hazardous gas destruction. The technology is currently being implemented in multiple standalone products for businesses, homes, and vehicles of all types -to move, sterilize and filter air, including removing allergens down to 14.6 nanometers, passing through our patented technology -replacing expensive outdated passive HEPA and other filtration type systems. There are broad ranges of additional markets for standalone and embedded Kronos CORE technology-based devices. Examples of immediately addressable markets include schools, universities, healthcare facilities, operating rooms, manufacturing clean rooms, and the cabins of automobiles and commercial aircraft.
Kronos is the first publicly traded Company that accepts DOGE coin as a form of payment for its products, as well as other cryptocurrencies.
Recently, the Company filed for a provisional patent involving an innovative protective face mask with antimicrobial and anti-cellphone radiation protection features. The Company is planning to file additional patents to improve its existing technology as well as enter into new market segments but will continue to market air purifiers and other consumer products. The Company is an exclusive distributor and licensee of the latest generation of air purifiers based on the Company's CORE technologies. The Company markets its products as Airdog® and KRONOS® brands. All Kronos products come with Kronos Promise ™ -Your Satisfaction is Guaranteed!
Company offices are located in Los Angeles, California.
Shopping portal: https://www.1800safeair.com
Follow KNOS on Twitter: https://twitter.com/kronosati
Follow KNOS on Facebook: https://www.facebook.com/kronosati
Follow KNOS on Instagram: https://www.instagram.com/kronos_ati/
Follow KNOS on Youtube: https://www.youtube.com/channel/UCdtrQDt1R26Ulh8v-S-EpJg
Follow KNOS on Reddit: https://www.reddit.com/user/Kronos_ATI
Follow KNOS on LinkedIn: https://www.linkedin.com/company/kronos-advanced-techngologies-inc
Contact us via info@kronosati.co or visit https://www.kronosati.co or https://www.1800SafeAIR.com
Disclaimer
This news release does not constitute an offer to sell, a solicitation of an offer to buy, or a recommendation of any security or any other product or service by Kronos Advanced Technologies Inc or any other third party regardless of whether such security, product, or service is referenced in this press release. Furthermore, nothing in this press release is intended to provide tax, legal, or investment advice, and nothing in it should be construed as a recommendation to buy, sell, or hold any investment or security or to engage in any investment strategy or transaction. Kronos Advanced Technologies does not represent that the securities, products, or services discussed in this press release are suitable for any particular investor. You are solely responsible for determining whether any investment, investment strategy, security, or related transaction is appropriate for you based on your personal investment objectives, financial circumstances, and risk tolerance. You should consult your business advisor, attorney, and/or tax and accounting advisor regarding your specific business, legal, or tax situation.
Social Media Disclaimer and Forward-Looking Statements.
Kronos Advanced Technologies investors and others should note that we announce material information to the public about the Company through various means, including our website (https://www.kronosati.co/investors), through press releases, OTCmarkets filings, public conference calls, via our corporate Social Media accounts, listed above. We encourage our investors and others to monitor and review the information we make public in these locations as such information could be deemed to be material information. Please note that this list may be updated from time to time.
Certain statements contained in this press release may constitute "forward-looking statements." Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the OTC Markets at OTCMarkets.com. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products.
The forward-looking statements included in this press release represent the Company's views as of the date of this press release, and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so.
These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.
SOURCE: KRONOS ADVANCED TECHNOLOGIES, Inc
Phone inquiries: 1-800-SAFE-AIR (option #4)
Correct! Hundreds of sites do use that number
The same number that Privco claims is HRI's contact number in this post.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164338520
That number obviously is not HRI's phone number and calls into question all of the other data listed for HRI on the Privco entry everyone was so excited about
Have you called that number Privco lists as HRI's phone number?
877-321-6755
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=164338520
They do not know who Health Resources, Univec, or David Dalton is
On that HRI "website"
You'll see on that page depicting the "card", it is simply a rebranding for this company as with all of the other cards associated with that phone number
https://unitednetworksofamerica.com/
The phone number in the Privco post is for this company, not HRI
I called the number in your post
877-321-6755
Not related to HRI, Univec, or David Dalton
If the data from Privco is correct
Why does it list HRI's phone number as the customer service number for an unrelated company? USA drug card?
If the phone number is incorrect, how can we trust the valuation information?
Los Angeles, CA, Feb. 09, 2021 (GLOBE NEWSWIRE) -- Los Angeles, CA, February 9, 2021 (GLOBE NEWSWIRE) -- KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) ("KNOS" or the "Company"), product development and production company that has significantly changed the way air is moved, filtered and sterilized, proudly announced today a USPTO filing for application for provisional patent protection for a first-ever air purifier with built in Dogecoin mining rig.
https://www.otcmarkets.com/stock/KNOS/news/story?e&id=1806565
Darren Thearle <dthearle@continentalstock.com>
10:55 AM (0 minutes ago)
to me, cstmail@continentalstock.com
Good Morning
we are not the current Stock Transfer Agent for the company you referenced. Our records show we were once the Stock Transfer Agent for the company, however, our Transfer Agent services terminated effective 11/21/18. We do not know of a successor agent, you would need to contact the company for assistance.
Thanks
On Mon, Jul 13, 2020 at 10:34 AM XXXX wrote:
Good Morning
Over the weekend, OTC markets profile for UNVC was updated to show “Transfer Agent Verified” and lists Continental as the TA. It was my understanding that Continental ceased being UNVC’s TA in 2018. Have you begun working for UNVC again or is this listing in error?
Thank you
You can buy one at a brew supply house
scroll down to the bottom of the page to see where they lifted the picture from.
https://www.brewbilt.com/products
identical pictures
http://simlatus.com/wp-content/uploads/2019/07/SIML-Proscere-Fact-Sheet-2019-07-15.pdf
it stays
Dalton will take care of himself
UNVC has been flushed by him just like the $51,000 AMEX bill he defaulted on along with the oan on his Lexus.
And lets not forget him stiffing the tuition at the Catholic school last year.
All of the Daltons are allergic to paying bills
Do you realize how much it costs to get current on 7 years of filings?? Well in excess of 6 figures
Also, when a person or company defaults on a loan, but does not file bankruptcy, the amount of the loan forgiven is considered income that tax must be paid on.
Do you realize how much taxes an penalties UNVC would owe if the loans were forgiven??? UNVC already has 6 figures worth of IRS liens on it already.
Also, the city of Baltimore has 6 figures worth of liens on UNVC for defaulting on the minority development loans given to Dalton and UNVC
Exactly
$5 million ... it was supposed to be 50/50. 50% to Kira. 50% presumably to pay down debt to the debtholder (Kira)
nodummy Wednesday, 05/08/13 08:08:48 AM
Re: stockmasterflash post# 43542
Post # of 131359
MMRF - Bob Lorsch
Operation Mole was original set up by him to figure out which of his employees was saying bad things about him to the regulators about 10 years ago
He recycled the name to use as his project to terrorize "bashers"
http://www.siliconinvestor.com/readreplies.aspx?subjectid=28509&nonstock=False&msgid=28044692
Direct quote from MMRF about how operation mole works (usernames removed)
"Heres how Operation Mole works: if anyone can lead me to the employers of xxxx or xxxx, or others whose names I will distribute in the future, I will contribute $500 to the charity of their choice or $300 to them. Then my lawyers can take it from there. You may wonder why I am doing this, the answer is simple……..I care! I care about the people who believe in me and I will not let them down. To claim a reward please call 888-808-4667 and mention Operation Mole."
Watch this video started after the 3:00 mark
How about all of those "business" trips to Australia on the company dime?
What business purpose ws Kira serving? And why is a talent agent based in Australia currently on the MMRF Board of directors?
And don't you think that the drug dealing personal assistatnt to the doctor that killed Michael Jackson is a poor choice to rescue MMRF????
The link is live
But it is not listed in the NEWS section. IN other words, if you didn't already have the link, you would not know it exists as they do not display that NEWS along with all of their othere NEWS
This press release
does not appear on the Argrimed website, nor does it appear on the Univec website. It has been removed from OTCMarkets.com at Dalton's request. Why???
Press Release
AGRiMED Industries Announces Cannabis Oil Partnership with Univec.
By
Published: Oct 2, 2017 4:26 p.m. ET
Why would KIra
give up what is rightfully hers, to lessen shareholder losses? Seriously?
the debts is owned by he
the patents are owned by her
the life insurance is owned by her.
She's just going to one day say, "I don't need all of this. These kind people have suffered enough losses. I'm going to share some of my stake with them as they are grieving the loss of Bob and his genius just as I am."
C'mon man!
Univec's lawyer Gregg Jaclin
Charged with bringing in straw man CEO's to head up Jaclin controlled companies. Geee, Sounds like Sterling Crockett will fit right in with Dalton and the gang.
http://www.teribuhl.com/2016/05/26/microcap-attorney-jaclins-co-conspirator-turned-doj-witness-in-shell-factory-scheme/
Microcap Attorney Jaclin’s Co-Conspirator Turned DOJ Witness in Shell Factory Scheme
This story has been updated
A 20-year veteran of Microcap financing deals, attorney Gregg Evan Jaclin, has been charged with running a shell-factory shop and securities fraud for nearly a decade. Yesterday I reported at Growth Capitalist the government has been building their case against Jaclin and his co-conspirator Imran Husain for years. Jaclin is accused of filing false opinion letters that allowed stock, which U.S. securities law says should be restricted, to freely trade within months of a private company going public through buying one of the Jaclin/Husain shells.
Jaclin, who denies the SEC charges, is currently working in the industry as the chairman of the corporate securities group at New Jersey-based Szaferman Lakind LLP. He lives in a million dollar home in West Windsor, NJ with his wife, Jill Gartenberg Jaclin, and their two kids.
Gregg And Jill Jaclin
Gregg And Jill Jaclin
Jaclin previously co-owned a law firm, Anslow & Jaclin, where he allegedly issued false SEC filings for the public shell companies named in the government’s complaint. Jaclin’s former partner Richard Anslow joined another top microcap financing law firm, Ellenoff Grossman & Schole LP, in October 2013. Anslow acknowledged he was interviewed in the SEC investigation of the shell factory scheme, according to his managing partner Doug Ellenoff. Ellenoff also told this reporter Richard Anslow doesn’t believe he is still part of the SEC investigation. I was able to ask Anslow face to face, at the Marcum Microcap Conference in NYC on June 1st, if the SEC had directly told him he is no longer part of the investigation, which centers on false filings and opinion letters written by a firm (Anslow+Jaclin) he co-owned. Anslow shook his head when I posed the question and started to walk away from me really fast. I followed him asking the question again along with asking “are you running away from a reporter’s questions”. Anslow escaped and I never got my answer. Anslow has not been charged by the government in this case.
The Securities and Exchange Commission complaint against Jaclin was filed by the regulator’s L.A. office in the district of Central California federal court on May 12, 2016. The SEC thanked the DOJ team in Northern California for assisting them in building their case but I found it odd they didn’t mention parts of Husain’s sworn plea agreement that talked about Jaclin’s role in coaching Husain, in 2012, to get some of the puppet CEO’s of the shell companies to lie to the SEC when the regulator began investigating who actually had control of the companies. It makes me wonder if these details are being saved for a DOJ criminal complaint against Jaclin. When I reached one of Husain’s lawyers, Victor Sherman, he told me he thought criminal charges were coming against Jaclin.
Nine shell companies were listed in the SEC complaint as being fraudulently built to look like real companies but in my investigation of the alleged scheme I found there were a lot more deals that fit the same pattern as described by regulators. Such as the case against Cary Lee Peterson who bought a shell from Jaclin and reverse merged a company called RVPlus. Although Peterson was arrested in March Paul Fishman, the head of the DOJ in New Jersey, didn’t get a jury to indict Peterson until May 10th- 2 days before the SEC filed their complaint against Jaclin. In the Peterson case the government quotes emails between Peterson and the “lawyer on the deal” negotiating the price of the shell. SEC records show that lawyer is Gregg Jaclin. Peterson is quoted saying ‘I’m not paying that price’ if the restriction on the legend for the shares isn’t removed so I can trade these shares within the first few months. Jaclin and Husain charged between $215k-$425k, which is high, per shell company they sold.
Private companies will pay more for a shell if it’s considered a ‘clean shell’. This means the public company has reported to the SEC for a year and it has a real business plan with at least 40 different shareholders. The scheme laid out in the SEC complaint says nominee shareholders were made up and Husain hired puppet CEOs to pretend to run the companies when it was really him pulling the strings. It’s those actions that are a BIG no-no, according to the SEC.
The New Jersey DOJ confirmed the RVPlus CEO, Cary Lee Peterson, was unable to post bail last week and had to get a public defender, which makes me wonder if the DOJ will also press him to turn government witness against Jaclin and others in the scheme. So far there are no public criminal charges against Jaclin but the pressman for the DOJ in Northern Cal reminded me there could be a sealed indictment against Jaclin that no one knows about.
Allegedly lying in SEC financials for public companies and writing false opinion letters isn’t the only thing Jaclin is culpable of. In 2011, Jaclin and his former law partner Richard Anslow made a press announcement that they were going to merge with a New York-based top-billing microcap law firm named Schenzia Ross Friedman Ference LLP. Yesterday, I reported at Growth Capitalist the merger quickly fell apart because the partners at Schenzia Ross were uncomfortable with some the deals Anslow+Jaclin worked on. Even though no merger docs were ever signed to form the new firm, I found Jaclin was signing opinion letters for S-1 filings with the firm name: Schenzia Ross Friedman Ference Anslow LLP in 2011 and 2012. One such filing was for Health Direct, an issuer listed in the SEC complaint against Jaclin. Harvey Kesner, a partner at Schenzia Ross, told me after reviewing the SEC filing of Health Direct with other partners of Schenzia Ross, “the filing was not on behalf of SRFF and the use of any portion of the firm name is unauthorized”. Signing the wrong law firm name could make an issuer’s S-1 filing considered a false opinion in the eyes of the SEC.
If the statements Husain made in his plea deal are true then Jaclin would have known the SEC investigation started as far back as at least August 2012 when one of their puppet CEO’s was called in for questioning. From that point on when the SEC started asking Jaclin questions he had a legal obligation to tell the issuers trading exchange, OTC Markets, that he was under investigation. OTC’s contract with attorneys who represent Issuers with opinion letters published on their trading platform clearly states under rule 12 in the Attorneys Agreement:
The letter must state to the best knowledge of counsel, after inquiry of management and the directors of the Issuer, whether or not the issuer of the Securities, any 5% holder, or counsel is currently under investigation by any federal or state regulatory authority for any violation of federal or states securities laws, and if so, the details of such investigation must be provided in such letter.
Imran Husain is the only co-conspirator of Jaclin’s named in the SEC complaint. But it’s possible more players in the microcap space will be arrested by the DOJ or charged with an enforcement action by the SEC. One name that comes to mind is microcap financer Barry Honig. I reported for Growth Capitalist the CEO of YesDTC, one of the issuers in the Jaclin complaint, was also arrested and made a plea deal with the DOJ in 2014. His name is Joe Noel. Noel and Husain both said in sworn testimony it was Barry Honig who bought the shell (created by Jaclin/Husain) that YesDTC merged into. The SEC successfully charged YesDTC for being a pump and dump. Noel then went on to say that Barry Honig ‘made him’ hire a stock promoter to aid in the pump and dump of YesDTC and alluded to the notion that Honig was also a control person in YesDTC. This matters because it affects Honig’s 9.99% investment in the company and his timing of when he can sell his shares. Honig has gone on the record through his attorney, Harvey Kesner, that he was not a control person of YesDTC, that he was cheated by Joe Noel, and Noel is lying in his DOJ plea statement. Honig has never been arrested or charged by the SEC for his role in investing in microcap stocks.
Editors Note: May 26 2016
When Jaclin learned I was reporting on him he called my cell phone late Friday night, which was the day after his SEC charges were announced, and left a voice mail he wanted to talk. It was past 9pm and I didn’t call him back that night. At 7am Saturday he then tried to write a somewhat threatening letter to an editor, Shelly Kraft, who he thought I was reporting for. Jaclin tried use the fact his firm had spent money sponsoring conferences of Kraft’s in the past and as a result he should be able to control the line of questioning I was doing researching his background. When I saw the emails Saturday I reminded Jaclin, via email, I am a freelance journalist who is isn’t controlled as a staff writer by any publication and if he had complaints they should come directly to me. I had also pointed out Shelly Kraft doesn’t own the publication I was planning on selling his story to. After that he refused to return my calls and asked for questions in email. Once he saw I had the DOJ secret plea deal from his co-conspirator I got an email late Saturday night that he’s hired an ex-SEC lawyer out of Colorado who instructed him not to comment on the case. But Jaclin couldn’t help himself and still tried to reach out to influence reporting on his case, this time to the correct editor of the publication I sell stories too; his goal appeared to be to muzzle me. Luckily I have an ethical and amazing editor at www.growthcapitalist.com who politely listened to Jaclin’s fear that reporting on his SEC fraud suit and other possible crimes is ’embarrassing his kids’ but my editor didn’t try to stop me from looking into other deals Jaclin might have done that are not legal and gather more evidence of his alleged crimes. The level of reporting and type of coverage I am allowed to do at www.growthcapitalist.com is unique, impactful, and full of details to help inform and warn the market. As a result the coverage is behind a paywall and you have to pay for it. I encourage anyone who invests in small cap stocks or cares about free markets to try subscribing. It’s worth it!
Back around 2009
I was investigating another real scummbag, Scott Sand of Ingen Technologies. He was also a debtor to Cory Ribotsky and when the FBI busted Sand (in addition to the SEC civil suit), Sand tried to roll on Ribotsky. Him and Cohen detailed how Dalton got out of bankruptcy by having UNVC take on another convertible even though the company was already in default to Ribotsky and that was cited in the SEC complaint against Ribotsky.
Jaclin getting busted only threw fuel on the fire. Not good for Dalton that the lawyer that signed off on all of Dalton's filings was busted for signing phony opinion letters and that Dalton's lender was busted for taking kickbacks from borrowers.
Now Crockett and his mafia ties??? LOL It's no wonder the scumbag never puts anything in writing.
I've met him several times
He can tell me Trump is appointing him Surgeon General and that Univec will replace Medicare. Or he could tell me I am right nd he is simply been unable to work since he was laid off by right Aid 2 decades ago.
The problem is the scumbag, David L Dalton does not put anything substantial in writing as he has seen what has happened to Crockett, Jaclin, Ribotsky, and Cohen.
I remember reading here all summer that in September UNVC was going to release a PR. LOL
Still waiting
How about
what is the nature of the "partnership" with Agrimed? What does Univec provide? What does Univec get? If he says the patch, ask him if Univec has ever sold any patches of any kind and to who.
Might want to ask who UNVC's auditor is and how they are getting paid as 6 years of financials will run 6 figures.
Maybe ask him why UNVC went dark in the first place.
Or how he manages to surround himself with so many criminals like Greg Jaclin, Bobby Cohen, Cory Ribotsky and Sterling Crockett.
And for the cherry on the sundae, ask him about how he intends to pay the liens on Univec that the IRS and the City of Baltimore has on it.
Maybe suggest the scumbag doctor put it all in a shareholder letter. Or maybe the deadbeat, scumbag, David L Dalton could a libel suit against Stockmasterflash.
Quote:But Pennsylvania state legislators were less convinced. “It's significantly concerning, and it brings into question the vetting process and how these companies were reviewed,” state rep. Eric Nelson (R-Greensburg) told the station.
State senator Jay Costa agreed. “We may need to go back and revisit the manner in which we conduct our investigations in terms of who is awarded these very valuable licenses,” Costa, (D-Forest Hills) said.
The cultivation licenses are being awarded by the Pennsylvania Dept. of Health, who declined to comment on Crockett or AGRiMED specifically. “If there is someone who cannot meet the standards under the law, that person would have to be replaced or the organization would have to find a remedy for that,” department spokesperson April Hutcheson told the station.
She acknowledged that the state is still performing background checks on applicants, even though some licenses have already been awarded. More than 140 of the companies who were declined Pennsylvania grower’s licenses are appealing the decision.
It said it right in the article
they didn't do any background checks beforehand. They're doing them now.
This is the same Univec
the same David Dalton
the Same Physician Pharmeceutical
the same health services inc
Dalton didn't suddenly transform from a fraudster into an upstanding citizent. Case in point, Univec "partners" with a company whose CEO was busted for being the straw man CEO of a Mafia controlled contracting scam
Leopards don't change their spots
If Amex won't give Dalton a card, neither should investors
We have relied on capital contributed by related parties, and such capital may not be available in the future.
During the years ended December 31, 2006 and 2005, Univec has repaid an aggregate of $455,517 to Pharmacy Services, Inc., Health Resources, Inc. and other companies all owned by Dr. David Dalton, President and Chief Executive Officer. These loans are repayable on demand at 10%, per annum. These repayment funds were primarily provided by notes and loans payable — long term. At December 31, 2006 and 2005, the aggregate balance outstanding was $123,283 and $815,510, respectively. Since 2004, PPSI shared office space and other administrative expenses with affiliated companies owned by Dr. Dalton. These expenses have not been allocated between the companies, but PPSI’s portion is insignificant.
Our future cash requirements will depend on many factors, including new acquisitions and distribution agreements. We do not expect to generate a positive cash flow from operations until we complete successful acquisitions and distribution agreements. We intend to seek additional funding through public or private financing transactions. Successful future operations are subject to a number of technical and business risks, including our continued ability to obtain future funding, satisfactory product development and market acceptance for our products.
Although we have been paying back these loans from Dr. Dalton and his affiliated companies, we may be unable to repay the remainder as planned and may have to look again to Dr. Dalton and his affiliated companies for assistance in financing if we are unable to obtain future financing. There is no guarantee that Dr. Dalton or his affiliated companies will have financial resources available to assist in our funding.
We have relied heavily on one customer owned by related parties, and such reliance may not be available in the future.
For the year ended December 31, 2006, our largest customer, Pharmacy Services, Inc., a company owned by Dr. David Dalton, our President and Chief Executive Officer, purchased goods which generated net revenues of $40,605 from PPSI’s GPO. This transaction represented 50% of total revenue. There is no guarantee that this customer will continue to buy our products. If this customer stops buying our products, or if we do not find additional customers to buy our products, then our future business prospects will be significantly limited and, as a result, it will have a material adverse effect on our business, results of operations and financial condition, and as a result, our business could fail and the trading price of our common stock would likely decline significantly.
https://www.sec.gov/Archives/edgar/data/1029825/000121390007001222/fsb2a40907_univec.htm
This comment by the SEC shows the true scumbag character of David Dalton
*** UNVC was a scam whereby UNVC bought product from a company owned by Dalton and then sold it to a different company owned by Dalton. ****
Note 4. Significant Accounting Policies, page F-7
-Revenue Recognition, page F-8
10. Please refer to prior comment 15. You previously disclosed
that
98% and 91% of your revenue for 2004 and 2003, respectively, was
derived from sales to one customer that is owned by your
president.
We have the following specific questions regarding your response:
* You state in your response that you have latitude in
establishing
the price of goods. You also state that you have discretion in
supplier selection and that that you retain absolute control over
which product is provided to the user. We note that your
president
is also the owner of your primary group purchasing operations
customer, PSI. In addition, we note your disclosure on page 9
that
Univec employs only four persons and that you utilize employees of
PSI to provide certain administrative services. Please provide us
with a revised analysis that takes into account the related party
nature of these transactions in evaluating the factors specified
in
EITF 99-19.
* Your response to prior comment 15 discusses latitude in
establishing prices in the context of the relationship between you
and the supplier. Please note the guidance in EITF 99-19 in this
regard refers to the establishment of prices between you and the
customer. Please provide us with a revised analysis of this
factor
as it relates to the relationship between you and your customer.
Your analysis should include specific discussion of how the
related
party nature of your negotiations with PPSI impacts this factor.
https://www.sec.gov/Archives/edgar/data/1029825/000000000005063145/filename1.txt
Note 17. Concentrations, page F-15
11. Please refer to prior comment 14. You state that Pharmacy
Services, Inc. is not a related party as defined in SFAS 57. You
further state that PSI is an affiliated private company wholly
owned
by the President of Univec. Please note the definition of related
party in Appendix B of SFAS 57 includes affiliated parties, which
are
defined as "parties that, directly or indirectly through one or
more
intermediaries, control, are controlled by, or are under common
control with an enterprise." We note from your disclosures on
page
18 of the Form 10-K/A that your president is the single largest
shareholder of Univec, owning 39.4% of the outstanding common
stock
of Univec as of August 31, 2004. Based on these facts, it appears
that PSI is a related party as defined in SFAS 57. Please revise
to
provide the required disclosures of paragraphs 2-4 of SFAS 57.
/filename1.txt
So in other words
there is no publicly accessible documentation of any operating Agrimed facilities. Like UNVC, the public gets lied to by a con man on the other end of a cell phone call.
And it's a surprise that the actual background check for Pennsylvania is becoming a problem??
Ever look at Bruce Goldman's background??? ROTFL Do any of these guys actually work for a living???
Where is Agrimed currently operating?
Everything Agrimed writes about is in the present tense. They are growing. They own dispensaries.....Where????
http://floridapolitics.com/archives/tag/agrimed-industries
Eric Mitchell: The right side of medical cannabis
Patients throughout the country are discovering alternative and compassionate ways to treat their chronic illnesses as states continue to open up laws for various kinds of medical cannabis. This is a remarkable opportunity for many individuals whose ailments have made day-to-day living an enormous challenge.
As a practicing physician specializing in pain management, I can guarantee that this is exactly what this medicine does. It greatly improves the lives of suffering patients with disabling diseases and provides individuals with the possibility to once again live healthy and productive lives.
For the past five years, I have validated that the standard and traditional medications have not been effective in controlling, stabilizing or rendering relief from chronic maladies. Also, in the past five years, through a state-approved alternative medical program, I have been able to grant patients a certificate, allowing them to use medical cannabis. In doing so, I have witnessed a marked reduction in the use of antidepressants, narcotics and other medicines that carry unfavorable side effects and possible addiction.
As the medical cannabis industry continues to make strides in revolutionizing health care, its impact has stretched far beyond its alternative designation given as a medicine.
For instance, states in the U.S. with legalized medical cannabis programs have lowered the usage of opioids in their region. Each year, these states have seen a 25 percent decrease in opioid overdose mortality rates compared against states that do not have medical cannabis laws.
This success is only possible because of the medical cannabis companies that continue to get it right. These are the companies that take a thoughtful approach to cannabis, making a difference in the lives of their patients and in the communities they serve. They bring in the highest caliber of medical professionals, scientists and compassionate caregivers, generating vigorously patient-centric programs and providing top-quality pharmaceuticals.
To be clear, these companies couldn’t be farther from the “pot shop” misperception currently plaguing the industry. The medical cannabis field is thriving because of companies with evident professionalism and a strong commitment to improving patient care – not because of those stigmatizing shops that disparage the industry’s great efforts.
AGRiMED Industries, where I currently serve as medical director, is a fully-integrated, minority-owned company and an exemplary model of today’s true medical cannabis industry.
By using state-of-the-art greenhouse facilities, AGRiMED produces consistent, high-quality medicine for patients. Our organization is led by a diverse team of business and medical professionals who are committed to improving the health and wellness of patients who can benefit from the positive scientific effects of cannabis-derived medicines. AGRiMED is also so much more.
The focus of AGRiMED’s leadership extends past medicine into the communities we serve. With a special interest in motivating and educating younger generations to achieve success, we have made it a company goal to build relationships with colleges, universities and medical centers so we can provide training and internships to students for early experience in the industry. We have done this with Lincoln University, a historically black institution, and intend to do the same with others, such as Bethune Cookman University.
After being recognized for its state-of-the-art greenhouse facilities, diverse leadership team and community involvement, our organization was scored the top medical cannabis company in Pennsylvania. This unique blend of quality production and skill is how we secured one of just 12 licenses issued for the entire the Commonwealth of Pennsylvania last year, and it is how we continue to remain at the forefront of the medical cannabis industry – an accomplishment we hope to bring to many other states.
Our success in Pennsylvania is just one example of how the medical cannabis industry can move mountains. With the ongoing commitment of companies like AGRiMED, medical cannabis will continue to improve the health and wellness of ailing patients who can benefit from this age-old plant’s positive effects.
___
Eric Ignatius Mitchell, M.D., MA, FACPE, CPE, is the current Medical Director for AGRiMED Industries, LLC. He is a practicing orthopedic surgeon and sports medicine doctor specializing in pain management from a telecommunication platform globally.
Guest AuthorOctober 26, 2017, 7:19 pm
AGRiMED, a passionate player deserves Florida medical marijuana license
If you had any doubts about the keen interest in medical marijuana in Florida, you don’t have to look any further than how quickly demand is outpacing supply.
That’s why the Florida Department of Health is preparing to issue five additional licenses for medical marijuana businesses in early October. The people want it, and entrepreneurs are racing to get to the front of the line to meet that demand.
It’s no surprise that medical marijuana is popular — better than seven out of 10 voters approved Amendment 2 last November. State officials are now required to issue the new licenses, which will help expand treatment options for individuals suffering from various debilitating diseases.
So far, most of the operators who have sought the highly prized — and potentially quite lucrative — licenses have focused on medical marijuana as an investment opportunity. But one of the candidates for the next round caught my eye because it approaches things from a different perspective, one very much affected by its founder’s personal experience.
AGRiMED Industries is among several applicants hoping to bring its business to Florida.
While doing some research on the latest contenders, I found that AGRiMED practically lapped the field in Pennsylvania, finishing miles ahead of everyone else in that state’s license process.
The organization’s CEO, Sterling Crockett, has since relocated to Florida. He brings with him an experienced and fully integrated company of dedicated professionals. But he also brings something else — the kind of inspiration that comes with almost losing a child.
Crockett came up with the idea for AGRiMED shortly after his daughter was diagnosed with kidney cancer — three weeks after giving birth to his first grandchild. His daughter suffered through the persistent and painful symptoms associated with her disease until Crockett helped her discover the tremendous healing benefits of medical cannabis. Today, Crockett cherishes every moment he can with his daughter and now granddaughter who is entering first grade.
With that experience pushing him forward, Crockett built AGRiMED with a focus on more than just the bottom line. To him, it’s also about sharing the medicinal benefits of cannabis-derived products, to help ailing people who can’t find relief any other way. To achieve his goal, he assembled a leadership team with over 200 years of collective medical and professional experience.
And AGRiMED is different in another way, too — it is a minority-owned and operated company that works to promote the next generation of minority entrepreneurs. Crockett, an African-American, aims to empower underserved and underrepresented communities to participate in the substantial growth potential of medical marijuana. In addition to funding research into the use of cannabis-derived medicines for sickle cell anemia, his company partnered with Lincoln University to provide internships and training to students for early experience in the industry.
I’m sure there are many worthy business operators among the individuals trying to land one of the five licenses the Department of Health will award soon. But wouldn’t it be nice to think there’s room in there for a company that was born of a passion for alleviating one woman’s suffering … that serves a minority community often overlooked by economic opportunity … and that works to build the next generation of executives?
Peter SchorschSeptember 25, 2017, 4:37 pm
Sterling Crockett: For one company, medical cannabis is personal
Last November, Florida voters revolutionized the way patients with debilitating diseases can pursue their road to recovery.
Following passage of Amendment 2, the Florida Constitution now allows licensed physicians to administer cannabis-derived medicines to individuals who suffer from a number of significant medical conditions.
In just a few short weeks, the Florida Department of Health – the agency responsible for regulating medical cannabis production and distribution centers – will issue licenses to five additional companies allowing them to grow and process cannabis plants.
The company I co-founded with my business partner Bruce Goldman, AGRiMed Industries, is among the applicants being reviewed by the department for these five licenses. For me, this is not just business – my desire to serve patients in need stems from a deeply personal family experience.
My journey with AGRiMED began shortly after I experienced the joy of learning I would be a grandfather, when my daughter Nicole was diagnosed with kidney cancer. Three weeks after giving birth to my first grandchild, Nicole had a kidney removed and began a 16-week regimen of chemotherapy. My daughter suffered nonstop from the symptoms associated with chemotherapy and the cancer itself, stealing precious time she should have been sharing with her newborn daughter.
Amid this adversity, medical cannabis gave Nicole a second chance to enjoy life in a way nothing else could. Thanks to the effective medical treatment she received, Nicole is now tumor-free and raising her beautiful daughter. After witnessing the significant medical benefits cannabis provided to her, the idea for AGRiMED was born.
Years later, our company is a fully integrated organization, bringing medical cannabis from cultivation to patient care. We’re not in the industry simply to grow it, sell it, and move on – we take great pride in our dispensary operations that put our legal product in the hands of patients who need it.
AGRiMED’s therapeutic professional-grade cannabis products are produced in state-of-the-art greenhouse facilities, ensuring consistent, contaminant-free medicines designed to treat a variety of patient conditions. Beyond that, our team of distinguished business and medical professionals, including acclaimed neurosurgeon Dr. Julian Bailes, fully integrates with the communities we serve, working with and educating local caregivers.
AGRiMED submitted the top scoring application to be awarded a grower/processor license in Pennsylvania, and we intend to bring that same level of professionalism to Florida. As a minority-owned company, we also are committed to supporting research into the use of cannabis for sickle cell anemia and working with historically black colleges and universities to provide training and internships to students for early experience in the industry. Our relationship with Lincoln University generates a knowledge center for cannabis-related research and development fueled by minority students, the first of its kind in the country.
As the medical use of cannabis becomes more common, it seems unreasonable to brand the plant’s qualities based on negative stereotypes. Our industry is extensively regulated and patient-centric, providing tangible relief to those who, like my daughter, truly need it.
AGRiMED is in the business of producing and selling high-quality medical cannabis, but to a greater degree we are really in the business of helping people whose ailments often make normal life unbelievably challenging. Whether by improving the health of patients or empowering underserved communities, we are committed to improving the health and wellness of ailing patients who can benefit from the positive effects of cannabis-derived medicines.
___
Sterling Crockett is CEO of AGRiMED Industries. AGRiMED Industries is a leading medical cannabis company committed to improving the health and wellness of ailing patients.
Guest AuthorSeptember 20, 2017, 1:25 pm
Follow @FLA_POL on Twitter
My Tweets
footerlogo.fw
Florida Politics is a statewide, new media platform covering campaigns, elections, government, policy, and lobbying in Florida.
Publisher: Peter Schorsch
Contributors and reporters: Phil Ammann, Mitch Perry, Jim Rosica, A.G. Gancarski, Ana Ceballos, Scott Powers, Bill Rufty, and Andrew Wilson.
Email: Peter@FloridaPolitics.com
Phone: (727) 642-3162
Address: 204 37th Avenue North #182,
St. Petersburg, Florida 33704
Tags
Adam Putnam Alan Grayson Alvin Brown Andy Gardiner Barack Obama Ben Carson Bernie Sanders Bill Nelson Bob Buckhorn Charlie Crist Corrine Brown Dana Young David Jolly Debbie Wasserman Schultz democrats Donald Trump Florida Florida Legislature Florida Senate Florida Supreme Court Gov. Rick Scott Gwen Graham headline Hillary Clinton Hurricane Irma Jack Latvala Jacksonville Jeb Bush Jeff Brandes Joe Negron Kathy Castor Lenny Curry Marco Rubio Medicaid Medical marijuana Orlando Pam bondi Patrick Murphy President Obama Richard Corcoran Rick Scott Ron DeSantis scroll Steve Crisafulli Ted Cruz
#FlaPol
Incumbent St Petersburg Mayor Rick Kriseman addresses the crowd Tuesdayhellip
These might be a little different than your resolutions FlaPol
Some stats on snowinflorida FlaPol
Its official The ucfknights are national football champions FlaPol chargeon
Incumbent St Petersburg Mayor Rick Krisemans SwearingIn Ceremony Tuesday athellip
Incumbent St Petersburg Mayor Rick Kriseman addresses the crowd Tuesdayhellip
These might be a little different than your resolutions FlaPol
Hide Buttons
Crockett pled guilty to being the straw man CEO of a Mafia run contracting scam
That he co-operated in the prosecution to receive a lesser sentence doesn't change the fact that he knew he was defrauding the government on behalf of the Mafia. He lied about it on his Pennsylvania Marijuana app and, he doesn't list that company on his Linkedin. He was CEO of the company receiving government contracts.
No mention of his ownership of Precision Abatement
https://www.linkedin.com/in/sterlingcrockett
And Crockett either lied about having a security clearance or lied on his SF-86 Government security clearance application
http://www.nytimes.com/1995/05/19/nyregion/12-charged-in-minority-businesses-scheme.html
Quote:The inquiry was started by Mr. Morgenthau's office two years ago as a spinoff from a labor racketeering investigation
Quote:Quote:But Pennsylvania state legislators were less convinced. “It's significantly concerning, and it brings into question the vetting process and how these companies were reviewed,” state rep. Eric Nelson (R-Greensburg) told the station.
State senator Jay Costa agreed. “We may need to go back and revisit the manner in which we conduct our investigations in terms of who is awarded these very valuable licenses,” Costa, (D-Forest Hills) said.
The cultivation licenses are being awarded by the Pennsylvania Dept. of Health, who declined to comment on Crockett or AGRiMED specifically. “If there is someone who cannot meet the standards under the law, that person would have to be replaced or the organization would have to find a remedy for that,” department spokesperson April Hutcheson told the station.
She acknowledged that the state is still performing background checks on applicants, even though some licenses have already been awarded. More than 140 of the companies who were declined Pennsylvania grower’s licenses are appealing the decision.
https://www.potnetwork.com/news/pennsylvania-medical-marijuana-ceo-fails-disclose-criminal-background
http://www.nytimes.com/1995/05/19/nyregion/12-charged-in-minority-businesses-scheme.html
The inquiry was started by Mr. Morgenthau's office two years ago as a spinoff from a labor racketeering investigation concerning the owners of the De-Con Mechanical Contractors Company in the Bronx. During the De-Con case, investigators overheard on court-authorized telephone taps conversations about the sham minority-owned companies, officials said.
The indictment also said the defendants cheated their employees, mainly immigrants from Poland and El Salvador, of $1 million by not paying them the wages required.
Joseph DiNapoli, 59, was described in the indictment as a capo, or captain, in the Lucchese crime family, and Louis DiNapoli, 56, was listed as a soldier in the Genovese family. Law-enforcement officials said members of different Mafia families often cooperate and share profits
According to the indictment, Asbestos Carting was so successful that the DiNapoli brothers organized P & T Excavation Corporation and Precision Abatement Corporation, both at 1821 Mahan Avenue in the South Bronx. The indictment said that Marguerite Trombetta, 37, of the Bronx was installed as the false owner of the P & T company and Sterling Crockett, 33, of Bayside, Queens, as the fake head of the Precision Company.
Pleading guilty to being a straw man CEO for a Mafia owned company
tends to be a disqualifier for being the CEO seeking a marijuana license. Politicians and government officials lose their jobs when they award contracts to scumbag criminals with Mob ties
Right after this incident
Crockett and GTI parted ways. Got pretty quiet in PA now too. LOL, those pesky Mafia conections
https://www.prnewswire.com/news-releases/gti-maryland-sues-maryland-medical-cannabis-commission-for-illegally-removing-pre--approval-of-gtis-grower-license-that-was-based-on-expert-review-300331063.html
GTI Maryland Sues Maryland Medical Cannabis Commission for Illegally Removing Pre- Approval of GTI's Grower License That Was Based on Expert Review
Just 48 Hours After Voting 5-0 to Accept RESI's Top 15 Recommendations, Commission Subcommittee Met Behind Closed Doors, Reversed Course and Improperly Substituted a Lower-Ranking Applicant for GTI
News provided by
GTI Maryland
Sep 20, 2016, 12:15 ET
GTI Maryland Sues Maryland Medical Cannabis Commission for Illegally Removing Pre- Approval of GTI's Grower License That Was Based on Expert Review
Just 48 Hours After Voting 5-0 to Accept RESI's Top 15 Recommendations, Commission Subcommittee Met Behind Closed Doors, Reversed Course and Improperly Substituted a Lower-Ranking Applicant for GTI
News provided by
GTI Maryland
Sep 20, 2016, 12:15 ET
Share this article
BALTIMORE, Sept. 20, 2016 /PRNewswire/ -- GTI Maryland, LLC announced at a press conference today that it has filed a lawsuit against the Maryland Medical Cannabis Commission (MMCC) and each of its 16 Commissioners for illegally removing GTI from the list of companies that had received pre-approval for opening cannabis grower operations in the state.
At the press conference, GTI officials and their attorneys described a closed-door reversal of a unanimous 5-0 vote by a Commission subcommittee on July 27, 2016 to recommend GTI and 14 other growers for licenses. Those 15 applicants, including GTI, had been rated the top picks based on an objective, "double-blind" evaluation conducted by Towson University's Regional Economic Studies Institute (RESI).
On July 29, just 48 hours later -- and without explanation -- 4 of 5 members of the subcommittee changed their votes and substituted two groups that failed to make the top 15 in place of GTI and another applicant that had made the top 15.
See attached for key facts. To obtain a copy of the complaint, please contact Eleanor McManus of Trident DMG at emcmanus@tridentdmg.com.
"We are filing this lawsuit because the Commission's removal of GTI from the top 15 list was improper and illegal," said Pete Kadens, CEO of GTI Maryland. "We earned pre-approval for a license, and we want what is rightfully ours. Any further delay will only hurt patients who need medical cannabis to ease their suffering."
"We want to know what happened in the 48 hours between July 27 and 29 to cause the subcommittee's turnabout," said GTI Maryland General Manager and businessman Sterling Crockett, Sr. "We want full transparency and disclosure about all contacts with subcommittee members during that time. We want to know if members spoke with or heard from anyone who caused them to change their minds."
Phil Andrews, an attorney for GTI at Baltimore law firm Kramon & Graham, noted that, on October 13, 2015 in response to questions from applicants, the Commission assured in published FAQ that "geographic diversity" would not be a factor for winning grower license pre-approval. Applicants relied on those responses, and the application requested no information about geography.
Yet, at the August 5, 2016 public Commission meeting, the MMCC subcommittee's stated reason for its course reversal was "geographic diversity," contradicting the Commission's own pronouncements and representations.
"There was no advance notice that the Commission and subcommittee had decided to change the rules, which GTI and other applicants relied on, after the game had been played," Andrews said.
Maryland legalized medical marijuana in 2013, and the MMCC is charged with reviewing applications for licenses to grow, process and cultivate cannabis for medical purposes. By statute, the state can allot only 15 licenses for growers until June 2018.
GTI Maryland applied for one of the 15 grower licenses in 2015 with operations to be located in Washington County. GTI immediately began to invest in its efforts and to work with local community leaders, who are supportive of GTI's application for a license.
GTI has a national track record of delivering treatment and patient care through medical cannabis. The company has dispensary and cultivation licenses, operations or partnerships in Illinois, Massachusetts, and Nevada, including six dispensary licenses and four cultivation licenses across these three states. In Illinois, GTI has served thousands of patients.
The lawsuit, which was filed Monday in Baltimore City circuit court, names as defendants the MMCC, the Maryland Department of Health and Mental Hygiene, and all 16 Commissioners, including: MMCC Chairman Paul W. Davies; Dario Broccolino, the State's Attorney for Howard County; John Gontrum, Assistant Comptroller of Maryland; Colonel Harry Robshaw, III, the Chief of Police of the Cheverly Police Department; and Allison W. Taylor, the Director of the Office of Governmental Affairs in the Maryland Department of Health and Mental Hygiene.
Andrews leads the litigation with former White House Special Counsel Lanny Davis serving as of counsel.
Davis joined Andrews, Kadens and Crockett at the press conference, along with former Baltimore Ravens player Eugene Monroe, who is a prominent educator on the benefits of medical cannabis and a GTI Maryland investor.
"We are asking the court to order the Commission to immediately restore GTI Maryland to its place on the list of 15 companies that were pre-approved for licenses," Andrews said.
Lanny Davis, a co-founder and partner at Davis Goldberg & Galper in Washington, D.C., said, "GTI asks for full disclosure and transparency from the Commission's subcommittee about why, within 48 hours, 4 of 5 members abandoned their unanimous acceptance of the merits-only list of 15 and instead substituted two lesser-ranked applicants."
Added Davis: "Without making any prejudgments, we want to know about all external conversations and contacts, if any, among the following: subcommittee members; the two lower- ranked companies; and lobbyists and representatives for those two companies. In addition, we ask whether the full Commission, which unanimously approved the subcommittee's revised list on August 5, was fully informed about any of those contacts before its vote. This is not a matter that should be restricted to the courtroom. Marylanders deserve answers."
Kadens commented: "We cannot lose sight of the fact that the real victims here are Maryland patients. They deserve access to the highest-quality treatment cultivated and delivered by the strongest companies. By allowing lesser-qualified applicants on the pre-approval list such as the company that replaced GTI, the Commission is preventing patients from getting the best care possible."
FACT SHEET
October 13, 2015: The Maryland Medical Cannabis Commission (MMCC), in its published responses to specific questions, stated that geographic considerations were "not relevant" to win pre-approval for a cannabis grower license, and, "[t]herefore, identification of multiple potential site locations is not necessary or helpful to the Commission at this stage." The MMCC also stated in another published response on the same day: "An applicant does not need to demonstrate that they are promoting geographical diversity in their choice of premises." GTI and other groups relied on those responses in preparing their applications.
November 6, 2015: Deadline for applicants to submit applications for medical cannabis grower licenses.
July 27, 2016: The MMCC's grower subcommittee voted unanimously (5-0) to grant pre- approvals for licenses to the top 15 ranked applicants as identified in an objective, merits-based list compiled by Towson University's Regional Economic Studies Institute ("RESI") after a months-long, "double-blind" review, scoring and ranking of the applications. This list included GTI, which ranked #12, and another entity that ranked #8.
July 29, 2016: 4 of 5 members of the grower subcommittee changed their votes and replaced GTI (#12) and the #8-ranked entity with two substantially lower-rated companies (#20 and #21). The subcommittee's chairman, Harry Robshaw, later said geographic considerations were the reason – contradicting the October 13, 2015 MMCC statement relied on by all applicants prior to submitting their applications.
August 5, 2016: The Commission unanimously voted on the subcommittee's July 29 list that resulted from the subcommittee's decision to reverse course and reject RESI's subject matter expert selection of the 15 best grower applications.
Contact:
Eleanor McManus
Emcmanus@tridentdmg.com
202-460-1451 cell
SOURCE GTI Maryland
Crockett is a BS artist
He tried to talk his way through the build out. But investors werent lining up throwing cash at him like he hoped and he ran out of cash. That's where Dalton came in Dalton knew a lot of scumbag moneymen and they tried to use Univec as a financing vehicle. Dalton's been out of the game way too long and even when he was, he wasnt very bright The years haven't been kind to him. Tax time this year won't be very much fun for him LOL
Crockett and Dalton deserve each other. Dumb and dumber
My sig was lifted from someone on this board
(sorry I forget who)
#1). You have money. Other people want it. All of it!
#2). You want easy money. So does everybody else. They'll get it, too....yours! (and all of it!)
#3). You tell yourself you're smart. You won't lose your money. Fact: Other people are smarter,
“Mark from aggrimed”?
Does “mark” have a last name and a title? Almost as ridiculous as Pennsylvania based Agrimed’s main business telephone being a Massachusetts cell phone number. But then again UNVC only has a cell phone number since UNVC has no offices or employees
Why was the Agrimed Univec partnership PR been removed from otcmarkets.com?
PWC, the liquidator controls the assets
shareholders only get a check at the end if PWC can't find enough ways to spend the recovery
Partnership news disappeared from OTC markets too
http://www.otcmarkets.com/stock/UNVC/news
AP NewsBreak: US to end policy that let legal pot flourish
By SADIE GURMAN
40 minutes ago
https://apnews.com/19f6bfec15a74733b40eaf0ff9162bfa?utm_campaign=SocialFlow&utm_source=Twitter&utm_medium=AP
WASHINGTON (AP) — Attorney General Jeff Sessions is rescinding the Obama-era policy that had paved the way for legalized marijuana to flourish in states across the country, two people with knowledge of the decision told The Associated Press. Sessions will instead let federal prosecutors where pot is legal decide how aggressively to enforce federal marijuana law, the people said.
The people familiar with the plan spoke on condition of anonymity because they were not authorized to discuss it before an announcement expected Thursday.
The move by President Donald Trump’s attorney general likely will add to confusion about whether it’s OK to grow, buy or use marijuana in states where pot is legal, since long-standing federal law prohibits it. It comes days after pot shops opened in California, launching what is expected to become the world’s largest market for legal recreational marijuana and as polls show a solid majority of Americans believe the drug should be legal.
While Sessions has been carrying out a Justice Department agenda that follows Trump’s top priorities on such issues as immigration and opioids, the changes to pot policy reflect his own concerns. Trump’s personal views on marijuana remain largely unknown.
Sessions, who has assailed marijuana as comparable to heroin and has blamed it for spikes in violence, had been expected to ramp up enforcement. Pot advocates argue that legalizing the drug eliminates the need for a black market and would likely reduce violence, since criminals would no longer control the marijuana trade.
The Obama administration in 2013 announced it would not stand in the way of states that legalize marijuana, so long as officials acted to keep it from migrating to places where it remained outlawed and out of the hands of criminal gangs and children. Sessions is rescinding that memo, written by then-Deputy Attorney General James M. Cole, which had cleared up some of the uncertainty about how the federal government would respond as states began allowing sales for recreational and medical purposes.
The pot business has since become a sophisticated, multimillion-dollar industry that helps fund schools, educational programs and law enforcement. Eight states and the District of Columbia have legalized marijuana for recreational use, and California’s sales alone are projected to bring in $1 billion annually in tax revenue within several years.
Sessions’ policy will let U.S. attorneys across the country decide what kinds of federal resources to devote to marijuana enforcement based on what they see as priorities in their districts, the people familiar with the decision said.
Sessions and some law enforcement officials in states such as Colorado blame legalization for a number of problems, including drug traffickers that have taken advantage of lax marijuana laws to hide in plain sight, illegally growing and shipping the drug across state lines, where it can sell for much more. The decision was a win for pot opponents who had been urging Sessions to take action.
“There is no more safe haven with regard to the federal government and marijuana, but it’s also the beginning of the story and not the end,” said Kevin Sabet, president and CEO of Smart Approaches to Marijuana, who was among several anti-marijuana advocates who met with Sessions last month. “This is a victory. It’s going to dry up a lot of the institutional investment that has gone toward marijuana in the last five years.”
Threats of a federal crackdown have united liberals who object to the human costs of a war on pot with conservatives who see it as a states’ rights issue. Some in law enforcement support a tougher approach, but a bipartisan group of senators in March urged Sessions to uphold existing marijuana policy. Others in Congress have been seeking ways to protect and promote legal pot businesses.
Marijuana advocates quickly condemned Sessions’ move as a return to outdated drug-war policies that unduly affected minorities.
Sessions “wants to maintain a system that has led to tremendous injustice ... and that has wasted federal resources on a huge scale,” said Maria McFarland Sanchez-Moreno, executive director of the Drug Policy Alliance. “If Sessions thinks that makes sense in terms of prosecutorial priorities, he is in a very bizarre ideological state, or a deeply problematic one.”
A task force Sessions convened to study pot policy made no recommendations for upending the legal industry but instead encouraged Justice Department officials to keep reviewing the Obama administration’s more hands-off approach to marijuana enforcement, something Sessions promised to do since he took office.
The change also reflects yet another way in which Sessions, who served as a federal prosecutor at the height of the drug war in Mobile, Alabama, has reversed Obama-era criminal justice policies that aimed to ease overcrowding in federal prisons and contributed to a rethinking of how drug criminals were prosecuted and sentenced. While his Democratic predecessor Eric Holder told federal prosecutors to avoid seeking long mandatory minimum sentences when charging certain lower level drug offenders, for example, Sessions issued an order demanding the opposite, telling them to pursue the most serious charges possible against most suspects.